Objective-Tissue factor (TF) triggers arterial thrombosis. TF is also able to initiate cellular signaling mechanisms leading to angiogenesis. Because high cardiovascular risk atherosclerotic plaques show significant angiogenesis, our objective was to investigate whether TF is able to trigger and stabilize atherosclerotic plaque neovessel formation. Methods and Results-In this study, we showed, by real-time confocal microscopy in 3-dimensional basement membrane cocultures, that TF in human microvascular endothelial cells (HMEC-1) and in human vascular smooth muscle cells (HVSMCs) plays an important role in the formation of capillary-like networks. TF silencing in endothelial cells and smooth muscle cells inhibits the formation of tube-like structures with stable phenotype. Using an in vivo model, we observed that TF inhibition in either HMEC-1 or HVSMCs reduced their shared ability to form new capillaries. The phenotypic changes induced by TF silencing were linked to reduced chemokine (C-C motif) ligand 2 (CCL2) expression in endothelial cells. Wound healing and chemotactic assays demonstrated that TF-induced release of CCL2 stimulated HVSMC migration to HMEC-1. Conclusion-Endogenous TF regulates CCL2 production in endothelial cells. Secreted CCL2 mediates the angiogenic effect of TF by recruiting smooth muscle cells toward endothelial cells and facilitates the maturation of newly formed microvessels. (Arterioscler Thromb Vasc Biol. 2011;31:2607-2615.)
A therosclerotic plaque angiogenesis, the outgrowth of new capillaries from preexisting vascular networks, is a pathological feature of advanced complicated plaques. 1, 2 Interestingly, coronary type VI plaques, according to the American Heart Association classification, are those with higher amount of microvessels and those with higher risk of inducing a clinical cardiovascular event. 3 In advanced plaques, inflammatory cell infiltration and concomitant production of proangiogenic cytokines may be responsible for induction of uncontrolled neointimal microvessel proliferation resulting in production of immature and fragile neovessels. The final stage of microvessel formation occurs when maturation requires the formation of tight endothelial cell-tocell contacts, 4 the downregulation of endothelial proliferation, and the deposition of a basal lamina to which the endothelium tightly adheres, as well as the recruitment of supporting cells to the vessel wall, such as pericytes and smooth muscle cells (SMCs). 5, 6 During angiogenesis, the communication between endothelial cells (ECs) and SMCs requires a precise temporal and spatial regulation of pro-and antiangiogenic molecules, but the process is not yet fully understood.
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In recent years, it has become clear that the angiogenesis process is highly dependent on components of the blood coagulation cascade. One of these proteins is tissue factor (TF). [7] [8] [9] TF is the cellular receptor and cofactor for blood coagulation factor VII (FVII). 10, 11 In addition to its primary role in blood coagulation, accumulating evidence has transformed our view of TF from the cellular receptor for activated FVII (FVIIa) to a multifaceted transmembrane signaling receptor. The biochemistry of TF-FVIIa and the transcriptional regulation of TF expression have been studied in depth. 8, 12, 13 However, it is not known whether TF may contribute to formation and stabilization of plaque microvessels. Previous studies have demonstrated that TFϪ/Ϫ mice resulted in embryonic lethality 14, 15 and that TF deficiency causes abnormalities of vascular pericytes, resulting in defective yolk sac vessel development and subsequent embryo wasting. 9 However, there is little information on the effects of vascular cells endogenous TF, either in ECs or in SMCs, on the mechanisms of atherosclerotic microvessel formation and maturation.
In the present study, we hypothesized that vessel wall TF could directly influence the formation of newly formed microvessels in atherosclerotic plaques, and we decided to identify which intracellular signaling molecules affected by TF might be involved in the process. Identification of key molecules involved in initiation or maturation of microvessels in the plaque may be of potential therapeutic and diagnostic importance. Here, we demonstrated that TF in both ECs and SMCs is required for forming complex stable microvessels and that this process is mediated by TF regulation of chemokine (C-C motif) ligand 2 (CCL2) expression in ECs.
Materials and Methods
The role of TF in tube formation was characterized using a 3-dimensional coculture system with human microvascular endothelial cells (HMEC-1) and human vascular smooth muscle cells (HVSMCs) by real-time confocal microscopy. In vitro wound healing and Transwell assays, as well as in vivo implantation of cell-loaded Matrigel plugs in nude mice were performed to investigate migration and angiogenesis. TF silencing was performed by small interfering RNA (siRNA) and enforced TF expression by lentivirus transfection. Real-time polymerase chain reaction and Western blot were performed to evaluate TF, CCL2, and vascular endothelial growth factor (VEGF) expression levels. Data were statistically analyze by the 2-tailed Student t test or by ANOVA. An expanded Methods section is available in the supplemental material, available online at http://atvb.ahajournals.org.
Results

TF Silencing Blocks Angiogenesis
To evaluate the impact of TF on microvessel formation, we characterized TF expression in human dermal microvascular endothelial cells (HDMECs) for 24 hours after seeding in 3-dimensional basement membrane (3D BM) cultures. TF expression was detectable at 2 hours, peaked at 4 hours, and decreased with time until complete abrogation at 24 hours (Supplemental Figure IA) . TF mRNA in HDMECs 3D BM cultures was analyzed by real-time quantitative polymerase chain reaction. Increases in TF mRNA levels followed a similar time-dependent pattern (Supplemental Figure IB) . Results were the same for primary HDMECs and the stable cell line HMEC-1; therefore, we performed the next experiments in HMEC-1 because no stable transfections could be obtained using HDMECs. However, key experiments were repeated using HDMECs.
To determine whether endogenous TF expression was required for capillary tube formation, TF gene was silenced in HMEC-1 cultured in 3D BM. After 18 hours of transfection, mRNA and protein levels were compared in scrambled-siRNA (control) and TF-siRNA cells. A reduction of 88Ϯ2.5% for mRNA levels in endogenous TF was observed ( Figure 1A ). Western blot showed the disappearance of the TF protein band ( Figure 1B ). The reduction in TF expression was accompanied by an inhibition of capillary-like branches in HMEC-1 cultured on 3D BM ( Figure 1C ). Quantification revealed a 5-fold reduction in total tube length and a 6-fold reduction in area covered by tubes in HMEC-1 TF-siRNA compared with HMEC-1 scrambled-siRNA ( Figure 1D ). Similarly, specific silencing of TF in HVSMCs induced a reduction of 80Ϯ5.0% in TF mRNA expression levels ( Figure 1A ) and a reduction of 90Ϯ5% in TF protein expression ( Figure 1B) . Also, HVSMCs treated with TF-siRNA showed a different phenotype compared with HVSMC scrambled siRNA ( Figure 1C ).
To exclude the possibility that there was apoptosis in response to inhibition of TF, we stained the cultures with TUNEL (Supplemental Figure IIA) . We observed a negligible amount of TUNEL-positive ECs or SMCs after TF-siRNA delivery (3Ϯ1% scrambled-siRNA versus 2Ϯ1% TF-siRNA in HMEC-1 and 1Ϯ0.2% scrambled-siRNA versus 0.75Ϯ0.15% TF-siRNA in HVSMCs, Supplemental Figure IIB ).
HVSMCs Promote Microvessel Stability and Needs TF Expression
Studies in 2-dimensional cultures had demonstrated that mural cells such as SMCs and pericytes may be important for stabilizing EC contacts. 16, 17 A coculture system of HMEC-1 and HVSMCs (at a ratio of 1:1) in 3D BM cultures was developed to investigate whether the presence of HVSMCs would affect endothelial capillary-like networks. Coculture of HVSMCs (green cells) and HMEC-1 (red cells) spontaneously formed tubes ( Figure 2A ), with HVSMCs localizing around the HMEC-1. Following the coculture by real-time confocal microscopy for 18 hours (see Supplemental Video I), we observed that initially, ECs began to move quickly to align themselves end-to-end and elongate, whereas SMCs remained quiet. ECs acted as modulators of the directionality of tube formation. Finally, HVSMCs started to migrate, contacted, and localized around the ECs, providing support and stability to the capillary-like structures ( Figure 2B ). Overall, HMEC-1 coculture with HVSMCs resulted in a faster and more extensive network of interconnecting tubes compared with HMEC-1 alone. Moreover, total length of the tubes formed on the coculture system greatly increased (2966.95Ϯ50 m in coculture versus 2500Ϯ25 m for HMEC-1 alone or 1500.57Ϯ65 m for HVSMCs alone; shown in Figure 1C and 1D). Similar results were obtained using HDMECs (Supplemental Figure III ).
Because TF downregulation was able to reduce tube-like formation of ECs and SMCs, we next examined the effect of TF silencing on tube formation and stabilization in the coculture assay. Differences were obvious as compared with scrambled-siRNA transfected coculture cells; TF silencing in HMEC-1 ( Figure 2C ), HVSMCs ( Figure 2D ), or both ( Figure  2E ) inhibited tube-like formation.
To confirm that changes in tube formation were due to TF silencing, we overexpressed full-length human TF by lentiviral transduction in ECs, as positive controls. TF upregulation in HMEC-1 significantly enhanced the formation of tube-like structures compared with controls transfected with empty lentivirus ( Figure 2F ).
Quantification of total tube length ( Figure 2G ) and area covered by tubes ( Figure 2H ) gave highly significant inhibi-
Human vascular smooth muscle cells (HVSMCs) promote vascular stability: silencing of tissue factor (TF) in coculture assays. Shown are endothelial cells (human microvascular endothelial cells [HMEC-1]) (red) and HVSMCs (green) in a 3-dimensional basement membrane (3D BM) coculture system for 18 hours. A, HVSMCs contacted HMEC-1 with their bodies and fine processes. B, Magnification of HVSMCs around the HMEC-1. C, HMEC-1 TF-small interfering RNA (siRNA) and HVSMC. Endothelial cells were not able to contact with each other, and they remained as individual cells. HVSMCs were organized in small clusters but failed to support any tube structure. D, HMEC-1 and HVSMC TF-siRNA. Endothelial cells formed significantly fewer tubes and resulted in a marked reduction (6-fold) of capillary growth and sprouting compared with control. HVSMCs were not able to contact with HMEC-1 and formed small clusters. E, HMEC-1 TF-siRNA and HVSMC TF-siRNA. Cells were not able to form any structure and remained as single cells. F, TF overexpression in HMEC-1 and HVSMCs. Overexpression of TF in endothelial cells was performed by stable transfection of cells with lentivirus expressing an N-terminal green fluorescent protein-TF fusion protein. Scale barsϭ300 or 30 m (nϭ6). G, Quantification of total tube length. H, Quantification of total area covered by tubes (%). Values represent meansϮSD from 6 different experiments (**PϽ0.001 vs control cells, †PϽ0.001 vs HVSMCs, #PϽ0.001 vs all the conditions).
tions by TF silencing. Silencing TF in ECs suppressed tube-like formation more efficiently than silencing TF in SMCs ( Figure 2G and 2H) .
Taken together, these data revealed that the microvascular ECs acted as modulators of the directionality of tube formation, and HVSMCs played an important role in cell-cell contact, directly participating in the formation of capillarylike networks; moreover, TF was shown to have a key role in coordinating the formation of the microvessels.
Inhibition of TF Blocks Angiogenesis in a Matrigel Plug Assay In Vivo
To provide evidence that inhibiting TF would also block the growth of microvessels in vivo, we subcutaneously inoculated nude mice with 1ϫ10 7 cocultured scrambled-siRNA or TF-siRNA cells in Matrigel plugs. The cells implanted in Matrigel plugs retained their viability and assured the sus-tained inhibition of TF over the course of the entire experiment (data not shown). The degree of neoangiogenesis was evaluated after 7 days. In control plugs removed from mice (coculture of scrambled-siRNAs transfected cells), angiogenesis was highly evident, and the main vessels were thick and showed frequent branching and abundant blood-filled channels containing red blood cells ( Figure 3A ). Similar results were obtained using HDMECs (Supplemental Figure IV) . When TF expression was silenced only in ECs (HMEC-1), a few infiltrating, single and elongated cells appeared without any apparent distribution ( Figure 3B ). In contrast, when TF was silenced in HVSMCs, we observed only single vessels full of red blood cells, but these microvessels were smaller in diameter compared with the controls and did not show branching ( Figure 3C ). A disorganized mesh of cells was found when TF was inhibited in both HMEC-1 and HVSMCs ( Figure 3D ). When TF expression was upregulated in HMEC-1 by lentiviral transfection, we observed a thick mesh of microvessels surrounded by a branching structure of microvessels, all of them containing red blood cells, indicating mature neovascularization ( Figure 3E ). Plugs without seeded cells did not show microvessel, excluding an angiogenic process derived from mouse cells in the experimental model ( Figure 3F ). Therefore, ECs with silenced expression of TF did not induce microvessel formation, whereas ECs with overexpression of TF formed an extended network of microvessel into the Matrigel implant.
One of the possible explanations for the reduced vessel density of capillaries and small vessels in the plug with TF-silenced cells could be an impaired stabilization of the newly forming vessels. To find out whether TF expression affected maturation of microvessels, we evaluated the density of vessels surrounded by mural cells by immunohistochemistry and double immunostaining (ECs, red; SMCs, green) of sections of the Matrigel plugs. In control plug sections, ECs surrounded by SMCs forming large mature microvessels were observed ( Figure 3A ). When we silenced TF in HMEC-1, HVSMCs, or both, the number of microvessels decreased significantly. In HMEC-1 TF-siRNA, we did not find any stable structure ( Figure 3B ). In TF-silenced HVSMCs, some tube-like structures of SMCs were observed that were only partially associated with ECs ( Figure 3C ). When we overexpressed TF in ECs, large microvessels formed, with many HMEC-1 and HVSMCs externally localized around them ( Figure 3E ; a higher magnification of Figure 3 is shown in Supplemental Figure V ).
All these results together indicate that TF is necessary to coordinate the formation of microvessels with a stable phenotype and that it is primarily TF expression in ECs that drives the microvessel formation process.
Downstream Effects TF to Regulate Angiogenesis: TF Induces CCL2 Expression in ECs
To ascertain the mechanism of action of TF in ECs in the triggering of microvessel formation, we studied downstream target genes regulated by TF. We performed an angiogenesis targeted microarray analysis to examine transcript abundance in control scrambled-siRNA and TF-siRNA-treated ECs. The analysis revealed that CCL2 was significantly downregulated in response to TF silencing (effects were seen at 4 hours and at 18 hours). To confirm the array results, we performed real-time polymerase chain reaction and Western blot analysis of control and silenced cells and verified that TF silencing blocked CCL2 expression. Overexpressing TF cells showed significantly higher expression of CCL2 mRNA and protein ( Figure 4A and 4B) .
Because CCL2 is a secreted protein, concentrations of CCL2 in EC culture supernatants were also examined. CCL2 concentration was markedly reduced in TF-silenced cells (46.28Ϯ2.8 pg/mL versus 267.42Ϯ5.5 pg/mL in control cells) ( Figure 4C ). Experiments with TF overexpression to confirm results showed a highly significant increase in CCL2 levels (471Ϯ3 versus 267.42Ϯ5.5 pg/mL in control cells). Similar effects on CCL2 were observed in HDMECs (Supplemental Figure VI) .
The microarray data showed a marginal effect of TF silencing in VEGF expression levels. Because VEGF is the most potent stimulator of angiogenesis and it has been reported to be upregulated by TF, 18 we investigated the effects of VEGF in the Matrigel assay with TF-silenced cells. VEGF mRNA and protein levels were not modified in TF-silenced cells; however, tube formation was not rescued by adding exogenous VEGF (20 ng/mL) to the TF-silenced cells ( Figure 4D to 4F) . These results demonstrated that TF-specific silencing inhibits tube formation downstream of VEGF. 
Arderiu et al Tissue Factor Induces Neovessel Formation
CCL2 Induces SMC Recruitment Toward ECs
Here we have shown that TF is necessary to stabilize the newly formed microvessel phenotype (Figures 2 and 3 ) and regulates CCL2 expression in ECs (Figure 4) ; therefore, we have hypothesized that CCL2 is in charge of recruiting SMCs to ECs to form the mature microvessels. We used 5 chemotaxis assay set ups to test our hypothesis. In all 5 setups, HVSMCs were seeded into the upper wells of Transwell chambers. In the lower wells, we added a different medium in each case: a control medium, medium plus platelet-derived growth factor, medium plus CCL2, and the supernatants from EC cultures obtained at 4 and 18 hours. Four hours later, cells migrating to the lower surface of the membrane were counted. CCL2 and EC culture media increased migration of HVSMCs. To evaluate whether TF was responsible for the increased migration induced by supernatant from ECs, we performed a similar experiment adding supernatants from TF-silenced HMEC-1 and TF upregulated HMEC-1. The effect was dramatically increased by the supernatants of TF-overexpressing ECs and reduced by supernatant of TFsilenced cells ( Figure 5A ). Because we observed that HVSMCs respond to CCL2 and that CCL2 acts through CCR2, we investigated expression levels of CCR2 in HVSMCs cultured with the different media for 4 and 18 hours. Figure 5B shows that expression of CCR2 was increased in HVSMCs in the presence of supernatants of ECs and TF-overexpressing cells, whereas HVSMCs incubated with supernatants of TF-silenced cells showed much lower levels. The addition of a potent CCR2 antagonist, RS-102895, inhibited the TF-CCL2-induced migratory effects on HVSMCs ( Figure 5C ).
All these results were confirmed by a wound healing assay carried out in a confluent HMEC-1 and HVSMC coculture system. At 24 hours after the scratch, the wound inflicted on each monoculture or on the coculture was completely repaired, whereas in cocultures with HMEC-1 TF-siRNA cells or in cells treated with RS-102895 (CCR2 antagonist) remained creviced. The addition of CCL2 rescued cells, and the wounds were repaired by HVSMCs in the coculture system ( Figure 5D ).
On the basis of these results, we focused our studies on the effect of TF and CCL2 on tube formation. 3D BM cocultures with the treatments described above were investigated. As shown in Figure 5E , although ECs formed tube-like structures, the CCR2 antagonist significantly interfered with the recruitment of HVSMCs to the formed tubes, whereas the addition of CCL2 to the 3D cocultures with TF-siRNA ECs induced formation of HVSMC (only) tubes around the TF-silenced ECs.
Taken together, these results suggest that endogenous TF regulates CCL2 expression in ECs, inducing the polarized migration of HVSMCs to the ECs to form mature structures.
Angiogenesis in Atherosclerotic Lesions of Human Coronary Arteries
TF-positive microvessels were searched in human coronary atherosclerotic plaques. Advanced human atherosclerotic coronary arteries show an extended network of microvessels. A representative plaque is shown in Supplemental Figure  VIIB in comparison with a human coronary with intimal thickening and without any indication of neovascularization (Supplemental Figure VIIA) . Double immunolocalization studies showed that TF expression (green) was found in new microvessels within atherosclerotic lesions colocalizing with ECs (red) (Supplemental Figure VIID) . Moreover, these ECs also express CCL2 (green) (Supplemental Figure VIIE) . TF expression (green) was also studied in SMCs (red) that surrounded the ECs (Supplemental Figure VIIF) . Together, these findings support our concept that TF induces CCL2 expression in ECs that stimulates SMC recruitment to the ECs to form mature structures.
Discussion
Microvessel formation in growing atherosclerotic plaques contributes to their risk of rupture and complications. TF is a mediator of intracellular signaling events that can alter gene expression patterns and cell behavior. The results from this study provide a new insight into how endogenous TF may regulate microvessel formation by demonstrating, in a modeled experimental setting, that TF expression is needed to promote newly formed microvessels. The functional changes induced by TF silencing are linked to reduced CCL2 expression, which in turn reduce the migration of SMCs toward ECs. Indeed, TF-mediated endothelial release of CCL2 promotes the recruitment of SMCs to ECs.
In this study, we used HMEC-1, an immortalized HMEC line that retains the morphological, phenotypic, and functional characteristics of normal HMEC. 19 HMEC-1 are very similar to primary HDMECs, and they can be genetically manipulated, providing a unique model with which to study the influence of TF in microvessel formation. We used siRNA because it is more sensitive, specific, and stable than antisense RNA.
A better understanding of how SMCs participate in angiogenesis is critical to increasing our knowledge of microvessel formation in the atherosclerotic plaques. To investigate the role of SMCs in EC neovessel formation, we designed a 3-dimensional coculture system with HVSMCs and HMEC-1 that allowed the observation of SMC-EC interactions in real time. Some authors have reported that pericytes and SMCs negatively regulate EC proliferation in vitro and in vivo. 20 On the other hand, mast cells 21 and mesangial cells 22 were reported to be recruited to sites of neovascularization and to release molecules that stimulated vascular tube formation. Moreover, a recent study demonstrated that macrophages expressing TIE2 and NRP1 interact with endothelial tip cells to promote vascular networking, thus increasing vascular complexity. 23, 24 In our study, we have clearly demonstrated that microvascular ECs modulate the direction of tube formation and that SMCs play an important role in cell-cell contact, directly participating in the formation of microvessels.
Contact interactions between cells seem to be effective for neovessel formation because SMCs secrete a high concentration of angiogenic molecules and because signaling pathways triggered by angiogenic factors in ECs may be enhanced by direct contact with SMCs. 25, 26 In this way, Zhang et al reported that SMCs stimulate TF expression in microvascular ECs. 27 Here, we show that EC-TF induces HVSMC recruitment and coordinates the formation of microvessels. Using a coculture system, TF-siRNA, and the Matrigel plug mouse model of angiogenesis, we showed that TF inhibition results in a dramatic decrease in neovascularization into the plug. These experimental data suggest that the effects are more significant when TF is silenced in HMEC-1 than in HVSMCs. These results are in agreement with previous data that indicate that TF plays a role in maintaining vascular integrity; the studies showed that complete deficiency of TF in TFϪ/Ϫ mice causes embryonic lethality by day 10.5 14, 15 and that TF deficiency causes abnormalities of vascular pericytes, resulting in defective yolk sac vessel development and subsequent embryo wasting 9 during embryogenesis. TF contributes to angiogenesis by activation of the coagulation cascade, as well as by coagulation-independent signaling events. 13 TF signaling pathways may be initiated both by TF-FVIIa protease activation and protein-activated receptors and by phosphorylation of the TF-cytoplasmic domain. 28 Indeed, TF cytoplasmic domain signaling alters vascular remodeling. 29 In addition to the full-length TF isoform, a second isoform, soluble alternatively spliced TF, has been described in humans and mice. 30, 31 Recently, alternatively spliced TF has been found to promote tumor growth and to be a proangiogenic factor. 32, 33 Alternatively spliced TF, unlike full-length TF, does not affect angiogenesis through proteinactivated receptor-dependent pathways but relies on integrin ligation. 34 We also investigated how TF can directly regulate angiogenesis. We report that TF silencing in ECs downregulates CCL2 (also called MCP-1/JE), a small cytokine belonging to the CC chemokine family. Previous results had shown that TF inhibition downregulated CCL2 in SMCs. 35 CCL2 has been identified as a potent chemotactic factor for monocytes, memory T cells, and dendritic cells to sites of tissue injury and infection. 36, 37 Initially, it was believed that CCL2 was responsible for stimulated angiogenesis through its chemoattractant effect on monocytes/macrophages, which in turn may release angiogenic molecules. 38, 39 However, it has been shown that CCL2 may also have a direct effect on angiogenesis. 40, 41 Our current findings suggest that CCL2 expression is modulated by TF in ECs. Indeed, we found that endogenous TF can promote microvessel stabilization through CCL2 expression, promoting via HVSMC-CCR2 migration to the newly formed endothelial tubes, which agrees with the finding that CCL2 stimulates SMC migration. 42 There are many studies describing correlations between TF and VEGF. 18 However, in the current investigation, we found that in TF-siRNA-transduced HMEC-1, there were no changes in VEGF gene expression or protein levels. The rescue experiments showed that addition of VEGF to TFsilenced cells did not restore the microtube formation capacity, showing that the effect of TF silencing is downstream of VEGF or even independent of VEGF. These data are consistent with observations from other studies that demonstrate that in cancer and SMCs, TF's effects on angiogenesis are independent of VEGF. 43, 44 In conclusion, we have identified a novel pathway by which TF promotes microvessel formation. Endogenous EC TF induces CCL2 secretion. The secreted CCL2 mediates the angiogenic effect of TF by recruiting HVSMCs toward ECs and facilitates the maturation of newly formed blood vessels. The understanding of signaling pathways triggered by TF to induce microvessels would generate molecular targets for plaque imaging and for therapeutic intervention against plaque neoangiogenesis. The impact of these pathways in human coronary atherosclerotic plaque microvessel formation is presently being investigated with laser dissection microscopy and microarray analysis of the human samples.
